News Chart Shattuck Labs, Inc.

Equities

STTK

US82024L1035

Real-time Estimate Cboe BZX Other stock markets 15:30:20 06/06/2024 BST			5-day change	1st Jan Change
7.205 ^USD	-2.50%		-3.37%	+0.42%

05-14	Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of Sl-172154 with Azacitidine in Frontline Higher-Risk Myelodysplastic Syndromes (Hr-Mds) and Tp53 Mutant Acute Myeloid Leukemia Patients At the European Hematology Association 2024 Congress	CI
05-02	Shattuck Labs, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

e07f39f368cf287b5df320e5cafae.3OoCqzJWFSC8jpr62KNMEim046TzhDi5Ojm7bAZ4E9w.vYtq0gdkRG3f462TqdskPx73oM3H5muMdgnDJExIIpS_u1PmWTQsVtDMww~4068c5481a4c2626c487405204ed733a